APPLICATION
ANDA211304
TYPE
ANDA
ORIGINAL APPROVAL
2021-08-24
LATEST ACTION
2024-10-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
METARAMINOL BITARTRATEPrescription
METARAMINOL BITARTRATE EQ 10MG BASE/ML · INJECTABLE · INJECTION
Approval history
2024-10-09Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.